Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin

Eur Respir J. 2020 May 7;55(5):1901903. doi: 10.1183/13993003.01903-2019. Print 2020 May.

¹ University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
² University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
³ University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
⁴ University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The Netherlands.
⁵ University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands johannes.alffenaar@sydney.edu.au.
⁶ Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
⁷ Westmead hospital, Sydney, Australia.
⁸ Marie Bashir Institute of Infectious Diseases and Biosecurity, Sydney, Australia.

No abstract available

Publication types